Science of Brain Plasticity
BrainBerry develops its technology based on the science of Brainplasticity in a personalised manner, to drive engagement with a suite of comprehensive modules and to maximise the benefits of using cognitive behavioral therapy for any patient.
Brain plasticity is the brain’s ability to adapt and change chemically, structurally and functionally at any age. Our technology effectively utilises neuroplasticity within its stimulation games to enable users to “rewire” their brains associations areas and emotional responses. The potential to offset and negate some of the damage sustained through focusing on re-wiring new areas of the brain
Our Clinical Trials
BrainBerry’s current clinical trials are focusing on how COSMA can positively impact as a CBT treatment both through standalone gamification and advanced EEG techniques to impact the lives of people with Alzheimer’s Disease symptoms.
| Pre-Clinical | Phase I | Phase II | |
| Mild Cognitive Impairment | ✓ | ✓ | |
| Alzheimer’s Disease | ✓ | ✓ | |
| Aged Healthy People | ✓ | ||
| Stroke | |||
| Insomnia |
Our Current Trials
Our Current Trials Phase I – COSMA as CBT Therapy with Alzheimer’s Patients – (2019 – 2021)
It is a randomised, comparative, two-arm clinical study to evaluate the effectiveness of gamified CBT COSMA app in Adults with Mild Neurocognitive Impairment and Dementia Associated with Alzheimer’s Disease.
Safety and Usability Study with COSMA Headset – 2022
Phase II – COSMA Neurofeedback Headset with Alzheimer’s Patients – (2022 – 2023)
Phase II Clinical Trials – COSMA Scoring Validation with Healthy Volunteers – 2022
Phase II – COSMA Neurofeedback Headset with Alzheimer’s Patients – (2022 – 2023)
It is a randomised, comparative, two-arm clinical study to evaluate the treatment effectiveness of COSMA Neurofeedback Headset in Alzheimer’s Disease.
Publications
Safety and Usability Study with COSMA Headset – 2022
It is a one arm study to conduct usability and safety study on both COSMA gamified app and headset as a Neurofeedback CBT system.
Phase II Clinical Trials – COSMA Scoring Validation with Healthy Volunteers – 2022
It is one arm study on healthy volunteers aged between 45-65 to get the weights on the cognitive measurements on the COSMA gamified app.
Alzheimer’s Disease – A Growing
Problem with Ageing Population
COSMA APP – Digital Therapy
COSMA is a personalised cognitive stimulation therapy designed specifically for people with Alzheimer’s Disease and Vascular Dementia. It is the first and only therapy to incorporate a truly personalised approach and undergo a continuous scientific and clinical approach to prove its efficacy.
COSMA Therapy is designed to help carers, doctors and family members understand the progression and symptoms of the disease and aims at achieving cognitive, emotional, and spiritual wellness for people living with Alzheimer’s Disease and Vascular Dementia.
COSMA Neurofeedback Treatment for Alzheimer’s Disease
BrainBerry is developing ‘COSMA Neurofeedback System’ consisting of a 12-electrode EEG headset with an AI-driven neurofeedback mechanism within a cloud-sever, that captures a patient’s brain wave activity whilst playing the COSMA CBT app, and autonomously tailors gaming therapies for each patient, shifting cognitive function over time towards that of a healthy person.
The COSMA monitoring headset device advances game therapy using brain data from the headset and brain-analytics algorithm, validating the gamification treatment.
The advanced COSMA-Neurofeedback-Device (Personalised Therapeutic Tool) embeds an AI-therapeutic algorithm that identifies a patient’s symptoms, automatically changing/selecting game therapies, targeting those symptoms
COSMA CBT APP
Diagnosis Of Dementia
Alzheimer’s Disease
Headset For Monitoring Sleep Disorders
Let’s work together on your
Al project
BrainBerry seeks to Partner with like-minded organisations, in order to help individuals, families, medical professionals and other interested parties aiming to combat neurological disorders.
Publications
